Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corlux for recurrent psychotic symptoms in PMD
NCT00208156Phase 3Completed
- Sponsor
- Corcept Therapeutics
- Start
- May 2005
- Primary completion
- Nov 2006
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of mifepristone, sponsored by Corcept Therapeutics. Started May 2005; status: completed.
02
Drugs
mifepristone
Beyond the preview
Go deeper on NCT00208156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00208156.